In recent news, Pakistan developed a new homemade vaccine called ‘PakVac’ with the help of China’s Cansino Bio after numerous testing and evaluation. Through this, the country aims to reduce its dependency on the COVID-19 vaccine.
Initially, the company started using vaccination provided by the government of China. The vaccination started with frontline healthcare and then senior citizens. As of now, Pakistan has now started the vaccination phase for citizens within the age of 30 and above.
Moreover, the Special Assistant to Prime Minister on Health Dr. Faisal Sultan commended the NIH Pakistan team on the successful development of the vaccine in a recent tweet.
He further added that the vaccine had passed the rigorous internal quality assurance testing as it was paramount. In addition to this, an official from the NHS stated that due to the agreement on technology transfer, the NIH would be able to produce over 3 million doses of ‘PakVac’ per month.
However, the Chinese vaccination i.e. CanSino would be available for citizens by the end of May and would slowly move on to PakVac.
On Thursday, the Pakistan Stock Exchange (PSX) 100 Index surged by 1,781.94 points, or 1.86%,…
Shaza Fatima Khawaja, Minister of State for IT and Telecom, made it clear on Thursday…
PayPal, the global payment processing company, announced on Friday that it had successfully resolved a…
LAHORE: Punjab government colleges have completed the recruitment of 7,354 teaching interns. The Higher Education…
The Pakistan Engineering Council (PEC) is launching a free six-week online training program on Generative…
The Pakistan Software Houses Association (P@SHA) has raised alarms about the severe impact of the…